February 24, 2026
Reading time • 5 min
Anvisa orders seizure of counterfeit cosmetics and medicines and warns of health risks
Anvisa ordered the immediate seizure of counterfeit batches of the drugs Mounjaro and Botox, manufactured by unknown companies with no safety guarantees. The measure, published in the Federal Official Gazette in February 2026, aims to protect consumers against adulterated units with suspicious labels and expiration dates that differ from the originals.
How to identify counterfeit Mounjaro medication?
The pharmaceutical company Eli Lilly do Brasil has identified counterfeit products circulating in the domestic market. The batch affected by the counterfeiting is D838838, which shows visible signs of tampering on the outer packaging. The regulatory agency has prohibited the storage and consumption of these items to avoid serious risks to patient health.
Subtle differences in packaging help users distinguish legitimate products from illegal copies. Poor print quality is the main warning sign, indicating that the manufacturing process did not follow the required standards. As a rule, consumers should check whether the name is slightly blurred.
How to verify the authenticity of medicines and compounded items?
You can check the status of various regulated products and companies on the Federal Government portal to validate batch numbers. Being wary of prices significantly below average is the first line of defense against counterfeiting. Original units from brands such as Eli Lilly have specific security features.
To maintain the safety of your treatments, adopt these immediate verification guidelines:
- Request a receipt and verify that the batch number matches the one printed on the packaging.
- Check that the seal is intact and that the expiration date information is clear.
- Use the manufacturers’ customer service channels to confirm the product’s legitimacy.
- Immediately report any suspicion of tampered or blurred products.
ANVISA agents removing products from the shelf
« Home
